ALGN (Align Technology) Change In Receivables : $-153 Mil (TTM As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Align Technology Change In Receivables?

Align Technology's change in receivables for the quarter that ended in Dec. 2024 was $-18 Mil. It means Align Technology's Accounts Receivable increased by $18 Mil from Sep. 2024 to Dec. 2024 .

Align Technology's change in receivables for the fiscal year that ended in Dec. 2024 was $-153 Mil. It means Align Technology's Accounts Receivable increased by $153 Mil from Dec. 2023 to Dec. 2024 .

Align Technology's Accounts Receivable for the quarter that ended in Dec. 2024 was $996 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Align Technology's Days Sales Outstanding for the three months ended in Dec. 2024 was 91.29.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Align Technology's liquidation value for the three months ended in Dec. 2024 was $-445 Mil.

Align Technology Change In Receivables Historical Data

The historical data trend for Align Technology's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Align Technology Change In Receivables Chart

Align Technology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-139.78

-262.07

21.55

-104.61

-153.49

Align Technology Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-24.32	-69.59	-77.34	11.69	-18.25

Align Technology Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-153 Mil.

Align Technology (NAS:ALGN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Align Technology's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	995.685	/	995.219	*	91
=	91.29

2. In Ben Graham's calculation of liquidation value, Align Technology's accounts receivable are only considered to be worth 75% of book value:

Align Technology's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1043.887	-	2362.615	+	0.75 * 995.685	+	0.5 * 254.287
=	-445

Align Technology Change In Receivables Related Terms

Thank you for viewing the detailed overview of Align Technology's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Align Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (NAS:ALGN) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

0HCK:UK AFW:Germany AFW:Germany A1LG34:Brazil ALGN:Austria

Address

410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85288

Website

https://www.aligntech.com

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Executives

Larkin C Raymond Jr	director	C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105
Joseph Lacob	director	2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Emory Wright	officer: VP, Operations	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Joseph M Hogan	director, officer: President and CEO	C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281
Kevin J Dallas	director	C/O ALIGN TECHNOLOGY INC., 2560 ORCHARD PARKWAY, SAN JOSE CA 95134
John Morici	officer: Chief Financial Officer	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Warren S Thaler	director	C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281
Anne Myong	director	2820 ORCHARD PARKWAY, SAN JOSE CA 95141
Julie Ann Coletti	officer: SVP, Chief Legal & Regulatory	2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Greg J Santora	director	4201 GRANT COURT, PLEASANTON CA 94566
Stuart A Hockridge	officer: VP, Global Human Resources	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
George J Morrow	director	AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Andrea Lynn Saia	director	C/O COCA-COLA ENTERPRISES, INC., 2500 WINDY RIDGE PARKWAY, NW, 14TH FLOOR, ATLANTA GA 30339
Thomas M Prescott	director	C/O ALIGN TECHNOLOGY INC, 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Yuval Shaked	officer: SVP and Mgng Director, Itero	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95134